Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET research.
RET Research News and Information
2025 RET Cancer Research Update
2025 RET Cancer Research Update
The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease
The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease
2025 RET Webinar: Meet Our Speakers
2025 RET Webinar: Meet Our Speakers
Join the POISE study at Massachusetts General Hospital
Join the POISE study at Massachusetts General Hospital
RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer
RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer
Announcing the Lung Cancer Genetics Study Database
Announcing the Lung Cancer Genetics Study Database
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials
RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)
RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
Cancer Cell Lines: Consider Donating to Advance Research
Cancer Cell Lines: Consider Donating to Advance Research
2025 IASLC Targeted Therapies Recap
2025 IASLC Targeted Therapies Recap
A Legacy of Hope in the Fight Against Lung Cancer
A Legacy of Hope in the Fight Against Lung Cancer
Announcing Lung Cancer Genetics Study & Lifebit Partnership
Announcing Lung Cancer Genetics Study & Lifebit Partnership
Lung Cancer Risk Factors: Understanding its Causes and Prevention
Lung Cancer Risk Factors: Understanding its Causes and Prevention
Why Donate to Lung Cancer Research?
